Evidence map›Paper›PMID 29906661›Full record

ArticleNeurobiology of aging2018

Loss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain.

Guillermo Carbajosa, Karim Malki, Nathan Lawless, Hong Wang, John W Ryder, Eva Wozniak, Kristie Wood, Charles A Mein, Richard J B Dobson, David A Collier and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Neurobiology of aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Trem2bioRxiv : the preprint server for biology · 2025
    Article
  6. Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer's disease through CB1 activation and inflammation modulation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Identification of the protective effect ofPharmaceutical biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Guillermo CarbajosaDepartment of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK. Electronic address: guillermo.carbajosa_antona@kcl.ac.uk.
Karim MalkiEli Lilly and Company, Windlesham, UK.
Nathan LawlessEli Lilly and Company, Windlesham, UK.
Hong WangEli Lilly and Company, Indianapolis, IN, USA.
John W RyderEli Lilly and Company, Indianapolis, IN, USA.
Eva WozniakBarts and the London Genome Centre, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, London, UK.
Kristie WoodBarts and the London Genome Centre, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, London, UK.
Charles A MeinBarts and the London Genome Centre, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, London, UK.
Richard J B DobsonDepartment of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London, UK.
David A CollierEli Lilly and Company, Windlesham, UK.
Michael J O'NeillEli Lilly and Company, Windlesham, UK.
Angela K HodgesMaurice Wohl Clinical Neuroscience Institute James Black Centre Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.
Stephen J NewhouseDepartment of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London, UK.
Eli Lilly (United Kingdom) · GBKing's College London · GBQueen Mary University of London · GBEli Lilly (United States) · US

Funding

KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7M
NIH HHS UM1 OD023221Wellcome Trust
6 · The paper itself

Abstract

Rare heterozygous coding variants in the triggering receptor expressed in myeloid cells 2 (TREM2) gene, conferring increased risk of developing late-onset Alzheimer's disease, have been identified. We examined the transcriptional consequences of the loss of Trem2 in mouse brain to better understand its role in disease using differential expression and coexpression network analysis of Trem2 knockout and wild-type mice. We generated RNA-Seq data from cortex and hippocampus sampled at 4 and 8 months. Using brain cell-type markers and ontology enrichment, we found subnetworks with cell type and/or functional identity. We primarily discovered changes in an endothelial gene-enriched subnetwork at 4 months, including a shift toward a more central role for the amyloid precursor protein gene, coupled with widespread disruption of other cell-type subnetworks, including a subnetwork with neuronal identity. We reveal an unexpected potential role of Trem2 in the homeostasis of endothelial cells that goes beyond its known functions as a microglial receptor and signaling hub, suggesting an underlying link between immune response and vascular disease in dementia.

Indexed as

Gene Expression RegulationAnimalsCerebral CortexEndothelial CellsGene Expression ProfilingGene OntologyGene Regulatory NetworksHippocampusMaleMembrane GlycoproteinsMice, KnockoutMicrogliaNeuronsReceptors, ImmunologicSequence Analysis, RNAMembrane GlycoproteinsReceptors, ImmunologicTrem2 protein, mouseAlzheimer's diseaseEndothelial cellsKnockout mouse modelRNA-SeqTREM2Weighted gene coexpression network analysis

Identifiers

PMID29906661
PMCPMC6075941
OpenAlexW2952433912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.